Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
Am J Ophthalmol ; 262: 186-191, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38191066

ABSTRACT

PURPOSE: To investigate the results of patients undergoing surgical treatment for strabismic diplopia in thyroid eye disease (TED) following teprotumumab. DESIGN: Multicenter, retrospective, case series. METHODS: We report 28 patients who underwent extraocular muscle surgery for strabismic diplopia after treatment with teprotumumab at 7 different academic centers. Elapsed time from last teprotumumab dose to the date of surgery, previous orbital decompression, primary preoperative horizontal and vertical deviation, surgical procedure, and 2-month postoperative results were collected from the patient records. RESULTS: Sixteen (57%) patients were diplopia-free after 1 surgery. Three (11%) chose prism spectacles to correct residual diplopia, 2 (7%) used compensatory head posture to resolve diplopia, and 1 (4%) had intermittent diplopia and was functionally improved (choosing no prisms or further surgery). These were considered treatment successes. Three (11%) patients required reoperation, and all were diplopia-free after their second procedure. CONCLUSIONS: Most patients requiring surgery for strabismic diplopia following teprotumumab achieve good outcomes with success rates comparable to series published before the availability of teprotumumab.


Subject(s)
Antibodies, Monoclonal, Humanized , Diplopia , Graves Ophthalmopathy , Oculomotor Muscles , Strabismus , Humans , Retrospective Studies , Male , Female , Oculomotor Muscles/surgery , Oculomotor Muscles/physiopathology , Middle Aged , Graves Ophthalmopathy/surgery , Graves Ophthalmopathy/drug therapy , Diplopia/physiopathology , Strabismus/surgery , Strabismus/physiopathology , Antibodies, Monoclonal, Humanized/therapeutic use , Aged , Adult , Treatment Outcome , Ophthalmologic Surgical Procedures , Decompression, Surgical , Vision, Binocular/physiology
2.
J Pediatr Ophthalmol Strabismus ; 57(4): 264-270, 2020 Jul 01.
Article in English | MEDLINE | ID: mdl-32687212

ABSTRACT

PURPOSE: To evaluate the effect of age at primary intraocular lens (IOL) implantation on rate of refractive growth (RRG3) during childhood. METHODS: A retrospective chart review was performed for children undergoing primary IOL implantation during cataract surgery. RRG3 was calculated for one eye from each patient using the first postoperative refraction, last refraction that remained stable (< 1.00 diopters [D] change/2 years), and the corresponding ages. RRG3 values for pseudophakic patients operated on from ages 0 to 5 months were compared with values for patients operated on at ages 6 to 23 months and 24 to 72 months. Patients with refractive errors that stabilized were grouped by age at surgery to compare age at refractive plateau. RESULTS: Of 296 eyes identified from 219 patients, 46 eyes met the inclusion criteria. There was a statistically significant difference in RRG3 among age groups. The mean RRG3 value was -19.82 ± 5.23 D for the 0 to 5 months group, -22.32 ± 7.45 D for the 6 to 23 months group (0 to 5 months vs 6 to 23 months, P = .43), and -9.64 ± 11.95 D for the 24 to 72 months group (0 to 5 months vs 24 to 72 months, P = .01). CONCLUSIONS: Age at primary IOL implantation affects the RRG3, especially for children 0 to 23 months old at surgery. Surgeons performing primary IOL implantation in infants may want to use age-adjusted assumptions, because faster refractive growth rates can be expected in young children. [J Pediatr Ophthalmol Strabismus. 2020;57(4):264-270.].


Subject(s)
Cataract Extraction , Eye/growth & development , Lens Implantation, Intraocular , Refractive Errors/physiopathology , Age Factors , Child , Child, Preschool , Eye/physiopathology , Female , Follow-Up Studies , Humans , Infant , Infant, Newborn , Male , Refraction, Ocular/physiology , Retrospective Studies , Visual Acuity/physiology
3.
J Pediatr Ophthalmol Strabismus ; 57: e30-e33, 2020 Mar 12.
Article in English | MEDLINE | ID: mdl-32176807

ABSTRACT

The authors describe a case of unilateral abducens nerve palsy following perinatal stroke of the middle cerebral artery. A 1-year-old boy presented with left eye esotropia but no other ocular abnormalities. The patient's history, examination, and diagnostic tests were consistent with abducens nerve palsy. He underwent left medial rectus recession of 5.5 mm and left lateral rectus resection of 7 mm followed by patching. At 15 months after surgery, primary gaze by prism alternate cover testing revealed a 4 prism diopter (PD) esophoria (small angle in left gaze with essentially no action of lateral rectus) and 2 PD right hyperphoria. Ophthalmologic management of abducens nerve palsy entails addressing neurological sequelae in a timely manner, treating the esotropia and strabismic amblyopia to optimize visual system development. [J Pediatr Ophthalmol Strabismus. 2020;57:e30-e33.].


Subject(s)
Abducens Nerve Diseases/etiology , Abducens Nerve Diseases/surgery , Ophthalmologic Surgical Procedures , Stroke/complications , Amblyopia/etiology , Amblyopia/surgery , Diagnosis, Differential , Esotropia/etiology , Esotropia/surgery , Humans , Infant , Male , Middle Cerebral Artery
5.
J AAPOS ; 21(4): 291-294, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28711580

ABSTRACT

BACKGROUND: Rectus muscle restriction is a common finding in thyroid eye disease (TED). Typically, restricted muscles are recessed to address strabismus and diplopia. However, some patients have residual strabismus following maximal recession of a restricted muscle. The purpose of this study was to report outcomes following resection of the lateral rectus muscle after maximal recession of the medial rectus muscle in patients with TED. METHODS: The medical records of patients with TED who underwent lateral rectus resection between 1998 and 2015 were reviewed retrospectively. Information regarding thyroid disease history and surgical treatment, including history of orbital decompressions, rectus muscle recessions, rectus muscle resections, and pre- and postoperative alignment was collected. Adjustable suture was used in all cases. Success was defined as a postoperative orthotropia with ≤2Δ of phoria at distance and a phoria at near. RESULTS: A total of 11 patients were included. Of these, 10 (91%) required postoperative adjustment. A successful outcome was achieved in 10 cases (91%). CONCLUSIONS: Lateral rectus muscle resection to address residual esotropia and diplopia was effective at reducing residual esotropia following medial rectus recession in our study cohort.


Subject(s)
Esotropia/surgery , Graves Ophthalmopathy/complications , Muscular Diseases/surgery , Oculomotor Muscles/surgery , Aged , Aged, 80 and over , Diplopia/etiology , Diplopia/surgery , Esotropia/etiology , Female , Humans , Male , Middle Aged , Muscular Diseases/etiology , Treatment Outcome
6.
Pediatr Blood Cancer ; 63(4): 627-33, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26599346

ABSTRACT

BACKGROUND: Approximately 30% of patients with metastatic (stage M) neuroblastoma present with periorbital ecchymosis from orbital osseous disease. Though locoregional disease is staged by imaging, the prognostic significance of metastatic site in stage M disease is unknown. We hypothesize that, compared to nonorbital metastasis, orbital metastasis is associated with decreased survival in patients with stage M neuroblastoma, and that periorbital ecchymosis reflects location and extent of orbital disease. PROCEDURE: Medical records and imaging from 222 patients with stage M neuroblastoma seen at St. Jude Children's Research Hospital between January 1995 and May 2009 were reviewed. Thirty-seven patients were <18 months of age at diagnosis and 185 were ≥18 months of age. Overall survival (OS) and 5-year survival (5YS) were compared for patients with and without orbital, calvarial and nonorbital osseous metastasis, and with and without periorbital ecchymosis (log-rank test). Associations of periorbital ecchymosis with orbital metastasis location/extent were explored (Fisher's exact test, t-test). RESULTS: In patients ≥18 months of age, only orbital metastasis was associated with decreased 5YS (P = 0.0323) and OS (P = 0.0288). In patients <18 months of age, neither orbital, calvarial, or nonorbital bone metastasis was associated with OS or 5YS. Periorbital ecchymosis was associated with higher number of involved orbital bones (P = 0.0135), but not location or survival. CONCLUSIONS: In patients ≥ 18 months of age with stage M neuroblastoma, orbital metastatic disease is associated with decreased 5YS and OS. In future clinical trials, orbital disease may be useful as an imaging-based risk factor for substratification of stage M neuroblastoma.


Subject(s)
Neuroblastoma/secondary , Orbital Neoplasms/secondary , Adolescent , Child , Child, Preschool , Ecchymosis , Female , Humans , Infant , Male , Neoplasm Staging , Neuroblastoma/mortality , Orbital Neoplasms/mortality , Proportional Hazards Models
7.
Ophthalmic Genet ; 37(2): 217-27, 2016 06.
Article in English | MEDLINE | ID: mdl-26331342

ABSTRACT

PURPOSE: To report longitudinal phenotypic findings in a patient with Sanfilippo syndrome type IIIA, harboring SGSH mutations, one of which is novel. METHODS: Heparan-N-sulfatidase enzyme function testing in skin fibroblasts and white blood cells and SGSH gene sequencing were obtained. Clinical office examinations, examinations under anesthesia, electroretinogram, spectral domain optical coherence tomography (SD-OCT), and fundus photography were performed over a 5-year period. RESULTS: Fundus examination revealed a progressive breadcrumb-like pigmentary retinopathy with perifoveal pigmentary involvement. SD-OCT showed loss of normal neuroretinal lamination and cystic macular changes responsive to treatment with carbonic anhydrase inhibitors. Electroretinography exhibited complex characteristics indicative of a generalized retinal rod > cone dysfunction with significant ON > OFF postreceptoral response compromise. Sequencing revealed compound heterozygous mutations in the SGSH gene, the novel c.88G > C (p.A30P) change and a second, previously reported one (c.734G > A, p.R245H). CONCLUSIONS: We have identified ocular features of a patient with Sanfilippo syndrome type IIIA harboring a novel SGHS mutation that were not previously known to occur in this disease - namely, a progressive retinopathy with distinctive features, cystic macular changes responsive to carbonic anhydrase inhibitors, and complex electroretinographic abnormalities consistent with postreceptoral dysfunction. SD-OCT imaging revealed retinal lamination changes consistent with previously reported histologic studies. Both the SD-OCT and the electroretinogram changes appear attributable to intraretinal deposition of heparan sulfate.


Subject(s)
Hydrolases/genetics , Mucopolysaccharidosis III/genetics , Mutation , Retinitis Pigmentosa/genetics , Adult , Electroretinography , Fibroblasts/enzymology , Humans , Male , Mucopolysaccharidosis III/diagnosis , Mucopolysaccharidosis III/enzymology , Retinitis Pigmentosa/diagnosis , Retinitis Pigmentosa/enzymology , Skin/cytology , Sulfatases/metabolism , Tomography, Optical Coherence
8.
J AAPOS ; 19(6): 526-30, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26691031

ABSTRACT

PURPOSE: To report our experince in establishing a sustainable pediatric surgical outreach mission to an underserved population in Guatemala for treatment of strabismic disorders. METHODS: A pediatric ophthalmic surgical outreach mission was established. Children were evaluated for surgical intervention by 3 pediatric ophthalmologists and 2 orthoptists. Surgical care was provided at the Moore Pediatric Surgery Center, Guatemala City, over 4 days. Postoperative care was facilitated by Guatemalan physicians during the second year. RESULTS: In year 1, patients 1-17 years of age were referred by local healthcare providers. In year 2, more than 60% of patients were prescreened by a local pediatric ophthalmologist. We screened 47% more patients in year 2 (132 vs 90). Diagnoses included congenital and acquired esotropia, consecutive and acquired exotropia, congenital nystagmus, Duane syndrome, Brown syndrome, cranial nerve palsy, dissociated vertical deviation, and oblique muscle dysfunction. Overall, 42% of the patients who were screened underwent surgery. We performed 21 more surgeries in our second year (58 vs 37), a 57% increase. There were no significant intra- or postoperative complications. CONCLUSIONS: Surgical outreach programs for children with strabismic disorders in the developing world can be established through international cooperation, a multidisciplinary team of healthcare providers, and medical equipment allocations. Coordinating care with local pediatric ophthalmologists and medical directors facilitates best practice management for sustainability.


Subject(s)
Community-Institutional Relations , Developing Countries , Medical Missions/organization & administration , Ophthalmologic Surgical Procedures , Patient Care Team/organization & administration , Strabismus/surgery , Adolescent , Child , Child, Preschool , Female , Guatemala , Humans , Infant , Male , Pediatrics , Vulnerable Populations
9.
Am Orthopt J ; 65: 87-93, 2015.
Article in English | MEDLINE | ID: mdl-26564932

ABSTRACT

BACKGROUND: Children with brain neoplasms often develop cranial nerve palsies (CNP) affecting ocular ductions. Duction deficits may improve or resolve with treatment of their intracranial disease. However, these children may be left with residual strabismus. METHODS: We identified 104 children with third, fourth, and/or sixth cranial nerve palsies who were treated for central nervous system (CNS) neoplasms. A retrospective chart review was conducted to determine the presence or absence of residual strabismus following resolution of duction deficits. RESULTS: Of the 104 children with CNP secondary to an intracranial neoplasm, forty-five had improvement or resolution of their duction deficit with treatment of their CNS lesion. Of these forty-five children, one had a third cranial nerve palsy, six had fouth cranial nerve palsies (one was bilateral), thirty-seven had sixth cranial nerve palsies (thirteen were bilateral), and one had two different cranial nerve palsies in the same eye (fourth and sixth). Of the eighteen children with improved (but not resolved) duction deficits, only three (17%) experienced resolution of their strabismus. Of the twenty-seven children with resolved duction deficits, nine (33%) experienced resolution of their strabismus. For the children with residual strabismus, the average angle of strabismus before duction deficits improved or resolved was 33.2Δ; while for those children without residual strabismus, it was 20Δ. CONCLUSIONS: Our findings indicated that the majority of children with improved or resolved duction deficits from CNP after treatment for CNS neoplasms are left with residual strabismus. Therefore, we suggest children with CNP secondary to CNS neoplasms need ophthalmic care after duction deficits resolve, as they are likely to have residual strabismus.


Subject(s)
Cranial Nerve Neoplasms/complications , Diplopia/etiology , Oculomotor Muscles/surgery , Oculomotor Nerve Diseases/complications , Ophthalmologic Surgical Procedures/methods , Strabismus/complications , Vision, Binocular/physiology , Adolescent , Child , Child, Preschool , Diplopia/physiopathology , Diplopia/surgery , Female , Follow-Up Studies , Humans , Infant , Male , Oculomotor Muscles/physiopathology , Oculomotor Nerve Diseases/physiopathology , Oculomotor Nerve Diseases/surgery , Retrospective Studies , Strabismus/physiopathology , Strabismus/surgery
10.
J AAPOS ; 19(4): 385-7, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26235796

ABSTRACT

Autopsy studies have described definitive traumatic avulsion of the oculomotor nerve from the brainstem; however, detailed characterization of mechanisms and localization of traumatic nerve injury has yet to be definitively described in vivo. We report the case of a 13-year-old girl in whom high-resolution magnetic resonance imaging confirmed irreversible injury to the left oculomotor nerve after trauma.


Subject(s)
Accidents, Traffic , Eye Injuries/diagnosis , Oculomotor Nerve Injuries/diagnosis , Adolescent , Eye Injuries/physiopathology , Female , Humans , Magnetic Resonance Imaging , Oculomotor Nerve Injuries/physiopathology , Visual Acuity/physiology
11.
J AAPOS ; 19(3): 247-51, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26059671

ABSTRACT

PURPOSE: To determine whether overcorrection shifts occur after vertical rectus recession on adjustable suture in the absence of thyroid eye disease. METHODS: The medical records of patients without thyroid eye disease who underwent vertical rectus recession surgery from 2001 to 2008 were retrospectively reviewed for shifts in alignment between suture adjustment at postoperative day 1 and 2 months' follow-up. Superior rectus and inferior rectus recessions were compared. In addition, we compared the use of a nonabsorbable polyester suture to an absorbable polyglactin 910 suture in nonthyroid patients undergoing inferior rectus recessions. RESULTS: A total of 59 patients were included (superior rectus, 30; inferior rectus, 29). We found a mean undercorrection shift of 1.1 (range, 17.5(Δ) undercorrection to 16(Δ) overcorrection) and 1.0(Δ) (range, 12(Δ) undercorrection shift to 6(Δ) overcorrection shift) for superior and inferior rectus recessions, respectively, between 1 day and 2 months postoperatively. CONCLUSIONS: There was no trend toward overcorrection following unilateral vertical rectus adjustable suture recessions in patients without thyroid eye disease, suggesting that thyroid myopathy may account for overcorrection shifts seen with this surgery.


Subject(s)
Ocular Motility Disorders/etiology , Oculomotor Muscles/surgery , Postoperative Complications , Strabismus/surgery , Suture Techniques , Adult , Aged , Female , Graves Ophthalmopathy/surgery , Humans , Male , Middle Aged , Polyesters , Polyglactin 910 , Retrospective Studies , Sutures , Vision, Binocular
12.
Vision Res ; 75: 77-87, 2012 Dec 15.
Article in English | MEDLINE | ID: mdl-22940089

ABSTRACT

PURPOSE: To characterize the phenotype of Bardet-Biedl syndrome (BBS) patients homozygous for the BBS1 M390R mutation. METHODS: Three patients [PT1, F, 27 years old (yo) at last examination, 14-year follow-up (F/U) PT2, F, 15-yo PT3, M, 15-yo, both 1-year F/U] underwent eye exams, Goldmann visual fields (GVFs), dark- (DA) and light-adapted (LA) electroretinograms (ERGs), spectral domain optical coherence tomography (SD-OCT) and fundus autofluorescence (FAF). Vision and systemic history were also collected. RESULTS: All patients had night blindness, hyperopic astigmatism, ptosis or mild blepharospasm, foot polydactyly, 5th finger clinodactyly, history of headaches, and variable, diet-responsive obesity. Two had asthma, PT1 was developmentally delayed, PT2 had Asperger-like symptoms, and PT3 had normal cognition. At age 14, acuity was 20/100 in PT1, who had nystagmus since age 2, 20/40 in PT2 and 20/30 in PT3. By 27yo PT1 progressed to 20/320, by 15 yo PT2 was 20/60 and PT3 remained stable. PT1 had well preserved peripheral GVFs, with minimal progression over 10 years of F/U. PT2 and PT3 presented with ring scotomas and I4e<5°. All patients had severe generalized visual sensitivity depression. ERGs were consistently recordable (also rod ERG in PT3 after 60 min DA), but progressed to non-recordable in PT1. Mixed DA ERGs exhibited electronegativity. In PT3, this was partly due to a bleaching effect during bright-flash DA averaging, partly to ON≫OFF LA response compromise. PT2 and 3 had, on SD-OCTs, generalized macular thinning, normal retinal lamination, and widespread photoreceptor outer/inner segment attenuation except foveally, and multiple rings of abnormal FAF configuring a complex bull's eye-pattern. PT1 had macular atrophy. All patients also had peripapillary nerve fiber layer thickening. CONCLUSIONS: The observed phenotype matches very closely that reported in patients by Azari et al. (IOVS 2006) and in the Bbs1-M390R knock-in mouse model, and expands it to the characterization of important ERG response characteristics that provide insight in the pathogenesis of retinopathy in these patients. Our findings confirm the consistent pathogenicity of the BBS1 M390R mutation.


Subject(s)
Bardet-Biedl Syndrome/genetics , Homozygote , Microtubule-Associated Proteins/genetics , Mutation/genetics , Retinal Diseases/physiopathology , Adolescent , Adult , Bardet-Biedl Syndrome/physiopathology , Electroretinography , Female , Fluorescein Angiography , Humans , Male , Phenotype , Retinal Diseases/genetics , Tomography, Optical Coherence , Visual Fields/physiology
14.
Int J Radiat Oncol Biol Phys ; 84(1): 46-51, 2012 Sep 01.
Article in English | MEDLINE | ID: mdl-22607912

ABSTRACT

PURPOSE: To assess visual outcome prospectively after conformal radiation therapy (CRT) in children with optic pathway glioma. METHODS AND MATERIALS: We used CRT to treat optic pathway glioma in 20 children (median age 9.3 years) between July 1997 and January 2002. We assessed changes in visual acuity using the logarithm of the minimal angle of resolution after CRT (54 Gy) with a median follow-up of 24 months. We included in the study children who underwent chemotherapy (8 patients) or resection (9 patients) before CRT. RESULTS: Surgery played a major role in determining baseline (pre-CRT) visual acuity (better eye: P=.0431; worse eye: P=.0032). The visual acuity in the worse eye was diminished at baseline (borderline significant) with administration of chemotherapy before CRT (P=.0726) and progression of disease prior to receiving CRT (P=.0220). In the worse eye, improvement in visual acuity was observed in patients who did not receive chemotherapy before CRT (P=.0289). CONCLUSIONS: Children with optic pathway glioma initially treated with chemotherapy prior to receiving radiation therapy have decreased visual acuity compared with those who receive primary radiation therapy. Limited surgery before radiation therapy may have a role in preserving visual acuity.


Subject(s)
Optic Nerve Glioma/radiotherapy , Radiotherapy, Conformal/methods , Visual Acuity/radiation effects , Adolescent , Algorithms , Antineoplastic Agents/therapeutic use , Child , Child, Preschool , Female , Humans , Male , Optic Nerve Glioma/drug therapy , Optic Nerve Glioma/physiopathology , Optic Nerve Glioma/surgery , Radiotherapy Dosage , Treatment Outcome , Tumor Burden , Visual Acuity/drug effects , Visual Acuity/physiology
15.
Am Orthopt J ; 61: 39-48, 2011.
Article in English | MEDLINE | ID: mdl-22069850

ABSTRACT

BACKGROUND AND PURPOSE: To review the surgical management of five vertical strabismus syndromes secondary to anatomical abnormalities. These syndromes are: 1) craniosynostosis; 2) "heavy eye syndrome" of high myopia; 3) Brown syndrome; 4) upshoot-downshoot in Duane retraction syndrome (DRS); and 5) antielevation syndrome after inferior oblique anteriorization. METHODS: The syndromes are presented from evolving to well-accepted surgical management practices based on review of the current literature. RESULTS: Surgical management techniques discussed include: 1) excyclotorsion of the muscle cones inducing elevation in adduction craniosynostosis, and surgery to stabilize the globe vertically in adduction in this situation; 2) loop myopexy to prevent prolapse of the elongated, highly myopic eye posteriorly between the superior and lateral recti; 3) superior oblique tenotomy and lengthening procedures to address inability to elevate the adducted eye in Brown syndrome; 4)Y-splitting of the lateral rectus to stabilize the adducted globe vertically in Duane retraction syndrome; and 5) re-recession of the anteriorized inferior oblique to a position posterior to the inferior rectus insertion in anti-elevation syndrome. CONCLUSIONS: The surgeon can, through careful surgical management techniques, alter the form of anatomy in these conditions and thereby provide more normally functioning binocular systems.


Subject(s)
Eye Abnormalities/complications , Oculomotor Muscles/surgery , Ophthalmologic Surgical Procedures , Strabismus/surgery , Eye Movements/physiology , Humans , Strabismus/etiology , Strabismus/physiopathology , Vision, Binocular/physiology
16.
Am Orthopt J ; 61: 117-23, 2011.
Article in English | MEDLINE | ID: mdl-21856879

ABSTRACT

INTRODUCTION AND PURPOSE: We evaluated the impact of developmentally-at-risk status on the results of photorefractive screening with iScreen®. PATIENTS AND METHODS: We sequentially recruited 169 children (aged 2-5 years) to participate in a blinded, prospective study of a photoscreening device. The principle investigator examined the children after photoscreening. Using established standards for amblyogenic factors, the principle investigator and photoscreen interpreters separately made a determination of "normal" or "needs referral" for each child. Sensitivity, specificity, positive predictive value, and negative predictive value for the photoscreening device were determined. RESULTS: Overall, sensitivity was 85% with a positive predictive value of 98%, and specificity was 87% with a negative predictive value of 47%. Developmentally-at-risk status in 34 children (three refused imaging) did not reduce sensitivity (89%) or specificity (100%) when compared with 130 children (two refused imaging) who did not have developmentally-at-risk factors (sensitivity = 84% and specificity = 80%). CONCLUSION: The efficacy of photorefractive screening in young children with developmentally-at-risk status is comparable to results found in normal children.


Subject(s)
Amblyopia/diagnosis , Developmental Disabilities/diagnosis , Retinoscopes , Vision Screening/instrumentation , Anisometropia/diagnosis , Astigmatism/diagnosis , Child, Preschool , Double-Blind Method , False Positive Reactions , Humans , Hyperopia/diagnosis , Myopia/diagnosis , Predictive Value of Tests , Prospective Studies , Reproducibility of Results , Risk Factors , Sensitivity and Specificity , Strabismus/diagnosis
17.
Arch Ophthalmol ; 129(2): 211-7, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21320969

ABSTRACT

OBJECTIVES: To report a child with early-onset autosomal recessive Best vitelliform macular dystrophy and compound heterozygous BEST1 mutations, the management of a choroidal neovascular membrane with intravitreal bevacizumab in the proband, the benefits of amblyopia therapy in the fellow eye, and the findings in the parents, carriers of heterozygous BEST1 mutations. METHODS: A 5-year-old white girl presented with monocular visual acuity loss and bilateral vitelliform macular lesions. Her parents were also examined. Examinations included electro-oculograms (EOGs), electroretinograms, imaging studies, and BEST1 gene testing. Interventions included off-label treatment with intravitreal bevacizumab in the left eye and amblyopia therapy in the right eye. RESULTS: The proband presented with visual acuity of 20/200 OD with an atypical subfoveal vitelliform scar and 20/16 OS with asymptomatic vitelliform deposits. Subfoveal choroidal neovascularization developed at age 6 years, causing marked vision loss (20/200 OS). Visual acuity recovered to 20/20 OS after serial intravitreal bevacizumab injections. Amblyopia therapy improved visual acuity to 20/50 OD. The proband showed subnormal EOG Arden ratios and mild electroretinogram changes. Molecular testing showed missense BEST1 mutations (R141S and R141H) in the proband. Unlike dominant Best vitelliform macular dystrophy, in the heterozygous parents EOGs were normal and minimal autofluorescence changes were seen. CONCLUSIONS: Choroidal neovascularization treatment with bevacizumab was associated with vision restoration. Amblyopia treatment also yielded significant benefit. Patients presenting with vitelliform lesions should be screened for BEST1 mutations, even when parents have normal EOG and imaging results. CLINICAL RELEVANCE: Prompt recognition and treatment of choroidal neovascularization and amblyopia management effectively restores vision. Awareness and recognition of recessive inheritance permits correct diagnosis and counseling.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Antibodies, Monoclonal/therapeutic use , Chloride Channels/genetics , Choroidal Neovascularization/drug therapy , Choroidal Neovascularization/genetics , Eye Proteins/genetics , Vitelliform Macular Dystrophy/drug therapy , Vitelliform Macular Dystrophy/genetics , Adult , Amblyopia/therapy , Antibodies, Monoclonal, Humanized , Bestrophins , Bevacizumab , Child, Preschool , Choroidal Neovascularization/diagnosis , Electrooculography , Electroretinography , Female , Genes, Recessive , Humans , Intravitreal Injections , Male , Mutation, Missense , Pedigree , Tomography, Optical Coherence , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Visual Acuity/physiology , Vitelliform Macular Dystrophy/diagnosis
18.
Trans Am Ophthalmol Soc ; 109: 168-200, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22253487

ABSTRACT

PURPOSE: Overcorrection of hypotropia subsequent to adjustable suture surgery following inferior rectus recession is undesirable, often resulting in persistent diplopia and reoperation. I hypothesized that overcorrection shift after suture adjustment may be unique to thyroid eye disease, and the use of a nonabsorbable suture may reduce the occurrence of overcorrection. METHODS: A retrospective chart review of adult patients who had undergone eye muscle surgery with an adjustable suture technique was performed. Overcorrection shifts that occurred between the time of suture adjustment and 2 months postoperatively were examined. Descriptive statistics, linear regression, Anderson-Darling tests, generalized Pareto distributions, odds ratios, and Fisher tests were performed for two overcorrection shift thresholds (>2 and >5 prism diopters [PD]). RESULTS: Seventy-seven patients were found: 34 had thyroid eye disease and inferior rectus recession, 30 had no thyroid eye disease and inferior rectus recession, and 13 patients had thyroid eye disease and medial rectus recession. Eighteen cases exceeded the 2 PD threshold, and 12 exceeded the 5 PD threshold. Statistical analyses indicated that overcorrection was associated with thyroid eye disease (P=6.7E-06), inferior rectus surgery (P=6.7E-06), and absorbable sutures (>2 PD: OR=3.7, 95% CI=0.4-35.0, P=0.19; and >5 PD: OR=6.0, 95% CI=1.1-33.5, P=0.041). CONCLUSIONS: After unilateral muscle recession for hypotropia, overcorrection shifts are associated with thyroid eye disease, surgery of the inferior rectus, and use of absorbable sutures. Surgeons performing unilateral inferior rectus recession on adjustable suture in the setting of thyroid eye disease should consider using a nonabsorbable suture to reduce the incidence of postoperative overcorrection.


Subject(s)
Oculomotor Muscles/surgery , Postoperative Complications/etiology , Strabismus/surgery , Suture Techniques/adverse effects , Adult , Aged , Aged, 80 and over , Diplopia/etiology , Diplopia/surgery , Female , Graves Ophthalmopathy/complications , Humans , Male , Middle Aged , Oculomotor Muscles/physiopathology , Retrospective Studies , Strabismus/etiology , Sutures/adverse effects , Treatment Outcome
19.
J AAPOS ; 14(3): 232-4, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20399694

ABSTRACT

BACKGROUND: An expected side effect of external beam radiation therapy for retinoblastoma is cataract formation, which impairs a child's visual development and an ophthalmologist's ability to examine the eye. When surgery is indicated, the potential complications can be vision-or life-threatening. Here we report the results of cataract extraction with intraocular lens placement in young children with retinoblastoma. METHODS: A retrospective chart review of all patients at St. Jude's Children's Research Hospital who had undergone external beam radiation therapy for retinoblastoma during a 25-year period was performed. Patients who required cataract extraction with IOL placement were included. Preoperative and postoperative visual acuity and ocular complications were recorded. RESULTS: The chart review identified 40 patients (53 eyes) with cataracts, of whom 15 (19 eyes) had surgery. Of the 19 eyes, 2 (10.5%) developed a vitreous hemorrhage (one of which was subsequently enucleated secondary to phthisis, whereas the other resolved without further complications). A total of 12 eyes (63.2%) required Nd:YAG laser capsulotomies (mean, 3.6 months; range, 1-7 months). None developed recurrence or spread of disease. Thirteen eyes (68.4%) had improved visual acuity after cataract extraction and intraocular lens placement, 4 of which (30.8%) subsequently lost vision as the result of other complications of retinoblastoma treatment. Visual acuity outcomes were 20/20 to 20/60 in 3 eyes (15.8%); 20/70 to 20/200 in 4 (21.1%); and 20/400 or less in 10 (52.6%). One patient (5.2%) required enucleation. CONCLUSIONS: Patients who underwent cataract extraction after treatment for retinoblastoma had few postoperative adverse outcomes, and visual acuity improved in most patients immediately after surgery. However, some patients who showed initial improvement subsequently lost vision as the result of other complications from retinoblastoma treatment.


Subject(s)
Cataract Extraction , Cataract/etiology , Radiation Injuries/surgery , Radiotherapy/adverse effects , Retinal Neoplasms/radiotherapy , Retinoblastoma/radiotherapy , Child, Preschool , Follow-Up Studies , Humans , Lens Implantation, Intraocular , Retrospective Studies , Treatment Outcome , Vision, Low/etiology , Visual Acuity
20.
J Pediatr Ophthalmol Strabismus ; 42(3): 185-8, 2005.
Article in English | MEDLINE | ID: mdl-15977874

ABSTRACT

We report a child with persistent fevers, arthritis, and parvoviral infection who subsequently developed unilateral orbital pseudotumor, lytic bone lesions, bilateral anterior uveitis, band keratopathy, and migratory polyarthritis. Our working diagnosis was systemic-onset juvenile rheumatoid arthritis, although pseudotumor of the orbit and lytic bone lesions are not found in this disease.


Subject(s)
Arthritis, Juvenile/complications , Orbital Pseudotumor/complications , Arthritis, Juvenile/diagnostic imaging , Arthritis, Juvenile/drug therapy , Child, Preschool , Drug Therapy, Combination , Female , Fibula/diagnostic imaging , Hand/diagnostic imaging , Humans , Naproxen/therapeutic use , Orbital Pseudotumor/diagnostic imaging , Orbital Pseudotumor/drug therapy , Osteolysis/complications , Osteolysis/diagnostic imaging , Parvoviridae Infections/complications , Parvovirus B19, Human/immunology , Parvovirus B19, Human/isolation & purification , Prednisolone/therapeutic use , Tibia/diagnostic imaging , Tomography, X-Ray Computed , Uveitis, Anterior/complications , Uveitis, Anterior/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...